Previous in vivo data (Zhang et al., 2013; Corsa et al., 2016) and data presented herein indicate that, at least in breast cancer cell lines and breast tumors, DDR2 inhibition has little effect on cell proliferation or survival. This evidence concerns the gene DDR2 and breast carcinoma.